Microvascular inflammation in atherosclerosis

IJC Metabolic and Endocrine

Volumn 3, Issue , 2014, Pages 1-7

  Vitiello, Laura ^a   Spoletini, Ilaria ^a   Gorini, Stefania ^a   Pontecorvo, Laura ^a   Ferrari, Davide ^b   Ferraro, Elisabetta ^a   Stabile, Eugenio ^c   Caprio, Massimiliano ^a   La Sala, Andrea ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Atherosclerosis; Inflammation; Microcirculation

Indexed keywords

ADIPONECTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 18; LEPTIN; NITRIC OXIDE; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR RISK; CELL INTERACTION; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INFLAMMATION; LEUKOCYTE; MICROCIRCULATION; MICROVASCULAR INFLAMMATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; UPREGULATION; ATHEROSCLEROTIC PLAQUE; NEOINTIMA; PHOSPHORYLATION; REPERFUSION INJURY; TISSUE INJURY; VASCULITIS; VASOCONSTRICTION;

EID: 84901482281     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2014.03.002     Document Type: Review

References (106)

1. Granger D.N., Senchenkova E. Inflammation and the microcirculation 2010, Morgan & Claypool Life Sciences, San Rafael (CA).
2. Tuma R.F., Duran W.N., Ley K. Microcirculation 2008, 1000. Academic Press. 2nd ed.
3. Pappano A.J., Weir W.G. Cardiovascular physiology 2013, Elsevier. 10th ed.
4. Simon S.I., Sarantos MR, Green CE, Schaff UY Leucocyte recruitment under fluid shear: mechanical and molecular regulation within the inflammatory synapse. Clin Exp Pharmacol Physiol 2009, 36(2):217-224.
5. Surks H.K. cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms. Circ Res 2007, 101(11):1078-1080.
6. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987, 2(8567):1057-1058.
7. Radomski M.W., Palmer R.M., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987, 148(3):1482-1489.
8. Goddard L.M., Iruela-Arispe M.L. Cellular and molecular regulation of vascular permeability. Thromb Haemost 2013, 109(3):407-415.
9. Rao R.M., Yang L, Garcia-Cardena G, Luscinskas FW Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007, 101(3):234-247.
10. Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006, 6(7):508-519.
11. Chavakis T., Preissner K.T., Santoso S. Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle. Thromb Haemost 2003, 89(1):13-17.
12. Granger D.N., Rodrigues SF, Yildirim A, Senchenkova EY Microvascular responses to cardiovascular risk factors. Microcirculation 2010, 17(3):192-205.
13. Harrison D.G. Endothelial function and oxidant stress. Clin Cardiol 1997, 20(11 Suppl. 2):11-17.
14. Jiang F., Gibson A.P., Dusting G.J. Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice. Eur J Pharmacol 2001, 424(2):141-149.
15. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87(10):840-844.
16. Berliner J.A., Watson A.D. A role for oxidized phospholipids in atherosclerosis. N Engl J Med 2005, 353(1):9-11.
17. Prasad A., Quyyumi A.A. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome. Circulation 2004, 110(11):1507-1512.
18. Patel M.J., Blazing M.A. Inflammation and atherosclerosis: disease modulating therapies. Curr Treat Options Cardiovasc Med 2013, 15(6):681-695.
19. Stokes K.Y., Clanton EC, Russell JM, Ross CR, Granger DN NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res 2001, 88(5):499-505.
20. Ishikawa M., Stokes KY, Zhang JH, Nanda A, Granger DN Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res 2004, 94(2):239-244.
21. Tailor A., Granger D.N. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol 2003, 23(4):675-680.
22. Nellore K., Harris N.R. L-arginine and antineutrophil serum enable venular control of capillary perfusion in hypercholesterolemic rats. Microcirculation 2002, 9(6):477-485.
23. Gauthier T.W., Scalia R, Murohara T, Guo JP, Lefer AM Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995, 15(10):1652-1659.
24. Stokes K.Y., Russell JM, Jennings MH, Alexander JS, Granger DN Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. Free Radic Biol Med 2007, 43(1):22-30.
25. Stokes K.Y., Clanton EC, Clements KP, Granger DN Role of interferon-gamma in hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circulation 2003, 107(16):2140-2145.
26. Stokes K.Y., Clanton EC, Gehrig JL, Granger DN Role of interleukin 12 in hypercholesterolemia-induced inflammation. Am J Physiol Heart Circ Physiol 2003, 285(6):H2623-H2629.
27. Lehr H.A., Kröber M, Hübner C, Vajkoczy P, Menger MD, Nolte D, et al. Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex. Lab Invest 1993, 68(4):388-395.
28. Weber C., Erl W, Weber KS, Weber PC Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. Clin Chem Lab Med 1999, 37(3):243-251.
29. Babior B.M. NADPH oxidase: an update. Blood 1999, 93(5):1464-1476.
30. Jackson S.H., Devadas S, Kwon J, Pinto LA, Williams MS T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004, 5(8):818-827.
31. Germano G., Sanguigni V, Pignatelli P, Caccese D, Lenti L, Ragazzo M, et al. Enhanced platelet release of superoxide anion in systemic hypertension: role of AT1 receptors. J Hypertens 2004, 22(6):1151-1156.
32. Kawashima S., Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24(6):998-1005.
33. Landmesser U., Hornig B., Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost 2000, 26(5):529-537.
34. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993, 341(8859):1496-1500.
35. Mugge A., Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 1991, 69(5):1293-1300.
36. McEver R.P. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002, 14(5):581-586.
37. Johnson R.C., Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997, 99(5):1037-1043.
38. Manka D., Collins RG, Ley K, Beaudet AL, Sarembock IJ Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein e-deficient mice. Circulation 2001, 103(7):1000-1005.
39. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69(1):11-25.
40. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110(6):673-687.
41. Muller W.A. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 1995, 57(4):523-528.
42. Nourshargh S., Krombach F., Dejana E. The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol 2006, 80(4):714-718.
43. Wegmann F., etri B, Khandoga AG, Moser C, Khandoga A, Volkery S ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 2006, 203(7):1671-1677.
44. Leon F., Contractor N, Fuss I, Marth T, Lahey E, Iwaki S, et al. Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol 2006, 177(10):6974-6982.
45. Nolte D., Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C mice. Am J Physiol 1994, 267(4 Pt 2):H1320-H1328.
46. Stokes K.Y., Clanton EC, Bowles KS, Fuseler JW, Chervenak D, Chervenak R The role of T-lymphocytes in hypercholesterolemia-induced leukocyte-endothelial interactions. Microcirculation 2002, 9(5):407-417.
47. Spiecker M., Liao J.K. Assessing induction of I kappa B by nitric oxide. Methods Enzymol 1999, 300:374-388.
48. De Caterina R., Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995, 96(1):60-68.
49. Nakayamada S., Takahashi H, Kanno Y, O'Shea JJ Helper T cell diversity and plasticity. Curr Opin Immunol 2012, 24(3):297-302.
50. Coquerelle C., Moser M. DC subsets in positive and negative regulation of immunity. Immunol Rev 2010, 234(1):317-334.
51. O'Shea J.J., Paul W.E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010, 327(5969):1098-1102.
52. Annunziato F., Cosmi L, Liotta F, Maggi E, Romagnani S Defining the human T helper 17 cell phenotype. Trends Immunol 2012, 33(10):505-512.
53. Eid R.E., Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119(10):1424-1432.
54. Gerdes N., Sukhova GK, Libby P, Reynolds RS, Young JL, Schönbeck U Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002, 195(2):245-257.
55. Packard R.R., Lichtman A.H., Libby P. Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 2009, 31(1):5-22.
56. Matsubara T., Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986, 137(10):3295-3298.
57. Eklund E.A., Kakar R. Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. J Immunol 1999, 163(11):6095-6105.
58. Ezekowitz R.A., Dinauer MC, Jaffe HS, Orkin SH, Newburger PE Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 1988, 319(3):146-151.
59. Niu X.L., Xia Y, Hoshiai K, Tanaka K, Sawamura S, Nakazawa H Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation. Nitric Oxide 2000, 4(4):363-371.
60. Dustin M.L., Rothlein R, Bhan AK, Dinarello CA, Springer TA Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986, 137:245-254.
61. J Immunol 2011, 186(9):5024-5033.
62. Chatzigeorgiou A., Karalis KP, Bornstein SR, Chavakis T Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012, 55(10):2583-2592.
63. Nishimura S., Manabe I, Nagasaki M, Seo K, Yamashita H, Hosoya Y, et al. In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest 2008, 118(2):710-721.
64. Nishimura S., Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 2007, 56(6):1517-1526.
65. Guzik T.J., Marvar PJ, Czesnikiewicz-Guzik M, Korbut R Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol 2007, 58(4):591-610.
66. Singer G., Granger D.N. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation 2007, 14(4-5):375-387.
67. Kato H., Kashiwagi H, Shiraga M, Tadokoro S, Kamae T, Ujiie H, et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol 2006, 26(1):224-230.
68. Konstantinides S., Schäfer K, Koschnick S, Loskutoff DJ Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001, 108(10):1533-1540.
69. Ouchi N., Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000, 102(11):1296-1301.
70. Ouchi N., Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100(25):2473-2476.
71. Cao R., Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001, 98(11):6390-6395.
72. Anfossi G., Russo I., Trovati M. Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis 2009, 19(6):440-449.
73. Giandomenico G., Dellas C, Czekay RP, Koschnick S, Loskutoff DJ The leptin receptor system of human platelets. J Thromb Haemost 2005, 3(5):1042-1049.
74. Crimi E., Ignarro L.J., Napoli C. Microcirculation and oxidative stress. Free Radic Res 2007, 41(12):1364-1375.
75. King G.L., Loeken M.R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004, 122(4):333-338.
76. Ouedraogo R., Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006, 55(6):1840-1846.
77. Son S.M., Whalin MK, Harrison DG, Taylor WR, Griendling KK Oxidative stress and diabetic vascular complications. Curr Diab Rep 2004, 4(4):247-252.
78. Bagi Z., Feher A., Beleznai T. Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species. Pharmacol Rep 2009, 61(1):99-104.
79. Stepp D.W. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond. Clin Exp Pharmacol Physiol 2006, 33(5-6):407-414.
80. Booth G., Stalker TJ, Lefer AM, Scalia R Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab 2001, 280(6):E848-E856.
81. Booth G., Stalker TJ, Lefer AM, Scalia R Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes 2002, 51(5):1556-1564.
82. Chavakis T., Bierhaus A, Al-Fakhri N, Schneider D, Schneider D, Witte S, Linn T, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003, 198(10):1507-1515.
83. Morigi M., Angioletti S., Imberti B., Donadelli R., Micheletti G., Figliuzzi M., et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998, 101(9):1905-1915.
84. Boodhwani M., Sellke F.W. Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal 2009, 11(8):1945-1959.
85. Gariano R.F., Gardner T.W. Retinal angiogenesis in development and disease. Nature 2005, 438(7070):960-966.
86. Wilkinson-Berka J.L. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 2006, 38(5-6):752-765.
87. Allen C.L., Bayraktutan U. Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability. Diabetes Obes Metab 2009, 11(5):480-490.
88. Funatsu H., Noma H, Mimura T, Eguchi S, Hori S Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 2009, 116(1):73-79.
89. Kim J.H., Kim JH, Yu YS, Cho CS, Kim KW Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. J Cereb Blood Flow Metab 2009, 29(3):621-628.
90. Phipps J.A., Clermont AC, Sinha S, Chilcote TJ, Bursell SE, Feener EP Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 2009, 53(2):175-181.
91. Sotiropoulos K.B., Clermont A, Yasuda Y, Rask-Madsen C, Mastumoto M, Takahashi J, et al. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J 2006, 20(8):1203-1205.
92. Carr M.E. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001, 15(1):44-54.
93. El Haouari M., Rosado J.A. Platelet function in hypertension. Blood Cells Mol Dis 2009, 42(1):38-43.
94. Henry M., Davidson L, Cohen Z, McDonagh PF, Nolan PE, Ritter LS Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice. Diabetes Res Clin Pract 2009, 84(1):11-18.
95. Henry M.L., Davidson LB, Wilson JE, McKenna BK, Scott SA, McDonagh PF, et al. Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes. Blood Coagul Fibrinolysis 2008, 19(2):124-134.
96. Ichikawa K., Yoshinari M, Iwase M, Wakisaka M, Doi Y, Iino K, et al. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis 1998, 136(2):281-287.
97. McDonagh P.F., Hokama JY, Gale SC, Logan JJ, Davis-Gorman G, Goldman S, et al. Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: chronic platelet activation in diabetic heart patients. J Diabetes Complications 2003, 17(5):269-278.
98. Rosenblum W.I., El-Sabban F., Loria R.M. Platelet aggregation in the cerebral and mesenteric microcirculation of mice with genetically determined diabetes. Diabetes 1981, 30(2):89-92.
99. Schafer A., Alp NJ, Cai S, Lygate CA, Neubauer S, Eigenthaler M, et al. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arterioscler Thromb Vasc Biol 2004, 24(9):1720-1726.
100. Winocour P.D., Perry D.W., Kinlough-Rathbone R.L. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding. Eur J Clin Invest 1992, 22(1):19-23.
101. Salas A., Panés J, Elizalde JI, Granger DN, Piqué JM Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. J Leukoc Biol 1999, 66(1):59-66.
102. Osmond J.M., Mintz JD, Dalton B, Stepp DW Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension 2009, 53(2):381-386.
103. Kusaka I., Kusaka G, Zhou C, Ishikawa M, Nanda A, Granger DN Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. Am J Physiol Heart Circ Physiol 2004, 286(6):H2442-H2451.
104. Terao S., Yilmaz G, Stokes KY, Ishikawa M, Kawase T, Granger DN Inflammatory and injury responses to ischemic stroke in obese mice. Stroke 2008, 39(3):943-950.
105. Panes J., Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, et al. Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 1996, 93(1):161-167.
106. Balakumar P., Singh H, Singh M, Anand-Srivastava MB The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res 2009, 60(1):18-23.